X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (116) 116
female (87) 87
index medicus (87) 87
male (79) 79
adult (55) 55
middle aged (50) 50
life sciences (43) 43
aged (34) 34
adolescent (31) 31
hematology (29) 29
oncology (26) 26
prognosis (24) 24
cancer (23) 23
mutation (21) 21
prospective studies (21) 21
immunology (20) 20
child (19) 19
young adult (19) 19
abridged index medicus (18) 18
animals (18) 18
france (18) 18
aged, 80 and over (17) 17
treatment outcome (17) 17
research (16) 16
[sdv.can]life sciences [q-bio]/cancer (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
mice (14) 14
retrospective studies (14) 14
disease (13) 13
genetic aspects (13) 13
internet (13) 13
risk factors (13) 13
[ sdv.can ] life sciences [q-bio]/cancer (12) 12
analysis (12) 12
article (12) 12
chemotherapy (12) 12
child, preschool (12) 12
elderly-patients (12) 12
expression (12) 12
gene expression (12) 12
doxorubicin - administration & dosage (11) 11
lymphoma, large b-cell, diffuse - drug therapy (11) 11
risk (11) 11
rituximab (11) 11
survival (11) 11
end-stage renal disease (10) 10
follow-up studies (10) 10
genetics (10) 10
genomics (10) 10
hodgkin lymphoma (10) 10
infant (10) 10
infectious diseases (10) 10
lymphomas (10) 10
medicine (10) 10
multivariate analysis (10) 10
mutations (10) 10
care and treatment (9) 9
cyclophosphamide (9) 9
diagnosis (9) 9
genes (9) 9
infant, newborn (9) 9
infections (9) 9
patients (9) 9
phenotype (9) 9
pregnancy (9) 9
survival analysis (9) 9
children (8) 8
combined modality therapy (8) 8
doxorubicin (8) 8
france - epidemiology (8) 8
hodgkin disease - drug therapy (8) 8
hodgkin disease - radiotherapy (8) 8
infection (8) 8
lymphoma, large b-cell, diffuse - genetics (8) 8
lymphoma, large b-cell, diffuse - mortality (8) 8
mutation - genetics (8) 8
transplantation (8) 8
vincristine (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
biochemistry, molecular biology (7) 7
cohort studies (7) 7
disease-free survival (7) 7
doxorubicin - therapeutic use (7) 7
gene (7) 7
gene expression profiling (7) 7
genetics & heredity (7) 7
genotype (7) 7
human health and pathology (7) 7
identification (7) 7
kidney failure, chronic (7) 7
microbiology (7) 7
mortality (7) 7
prednisone - administration & dosage (7) 7
studies (7) 7
therapy (7) 7
age (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
biology (6) 6
bleomycin - administration & dosage (6) 6
comparative analysis (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 07/2011, Volume 118, Issue 1, pp. 37 - 43
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 7, pp. 1466 - 1469
Inactivating mutations of the Ten-Eleven Translocation 2 (TET2) gene were first identified in myeloid malignancies and more recently in peripheral T-cell... 
TRANSFORMATION | IDH2 MUTATIONS | FREQUENT | 5-METHYLCYTOSINE | GENES | LEADS | MYELOID MALIGNANCIES | DIFFERENTIATION | PROTEINS | HEMATOLOGY | EXPRESSION
Journal Article
Experimental Eye Research, ISSN 0014-4835, 10/2019, Volume 187, p. 107747
Preclinical and clinical evidences show that aldosterone and/or mineralocorticoid receptor (MR) over-activation by glucocorticoids can be deleterious to the... 
RNA sequencing | Retina | Inflammation | Mineralocorticoid receptor
Journal Article
Blood, ISSN 0006-4971, 09/2016, Volume 128, Issue 11, pp. 1490 - 1502
Journal Article
Blood, ISSN 0006-4971, 11/2015, Volume 126, Issue 22, pp. 2466 - 2474
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Summary Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESPONSE CRITERIA | AGGRESSIVE LYMPHOMAS | POOR-PROGNOSIS | NON-HODGKINS-LYMPHOMA | REGIMEN | YOUNG-PATIENTS | ELDERLY-PATIENTS | DES-LYMPHOMES | TRANSPLANTATION | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2016, Volume 22, Issue 12, pp. 2919 - 2928
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 1066 - 1073
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 12, p. e14398
Background: Changes in imprinted gene dosage in the placenta may compromise the prenatal control of nutritional resources. Indeed monoallelic behaviour and... 
BOVINE BLASTOCYSTS | MURINE PLACENTA | ORGANIC CATION TRANSPORTERS | NUTRIENT TRANSPORT | ADAPTIVE RESPONSES | TROPHOBLAST DIFFERENTIATION | MULTIDISCIPLINARY SCIENCES | FETAL-GROWTH | EPIGENETIC REGULATION | MATERNAL UNDERNUTRITION | HUMAN CHORIONIC-GONADOTROPIN | Pregnancy, Animal | Dietary Fats - metabolism | Genomic Imprinting | Epigenesis, Genetic | Gene Expression Regulation | Male | Gene Dosage | Placenta - metabolism | Pregnancy | DNA Methylation | Animals | Alleles | Sex Factors | Female | Mice | Animal Feed | Epigenetic inheritance | Chromatin | Genes | Genomics | Genomes | DNA binding proteins | Genetic transcription | Epidemiology | Diet | Pregnant women | DNA | Physiological aspects | Genetic research | Book publishing | Comparative analysis | Methylation | Neurosciences | Deregulation | Transcription factors | Breastfeeding & lactation | Laboratories | Biological evolution | Sex | Cardiovascular disease | Dimorphism | Gestation | High fat diet | Rodents | DNA methylation | Clusters | Life sciences | Sexual dimorphism | Chromosomes | Chromosome 17 | Deoxyribonucleic acid--DNA | CpG islands | Hypertension | Gene dosage | Obesity | Sensitivity analysis | Nutrition | Cloning | Metabolism | Gene expression | Embryos | Chromatin remodeling | Studies | Offspring | Hypotheses | Sensitivity | Placenta | Womens health | Sexes | Preeclampsia | Quality control | Epigenetics | Binding sites | Deoxyribonucleic acid
Journal Article